Correlation Between SCANSOURCE (SC3SG) and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SCANSOURCE (SC3SG) and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANSOURCE (SC3SG) and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SCANSOURCE and Eli Lilly and, you can compare the effects of market volatilities on SCANSOURCE (SC3SG) and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANSOURCE (SC3SG) with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANSOURCE (SC3SG) and Eli Lilly.

Diversification Opportunities for SCANSOURCE (SC3SG) and Eli Lilly

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between SCANSOURCE and Eli is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding SCANSOURCE and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and SCANSOURCE (SC3SG) is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANSOURCE are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of SCANSOURCE (SC3SG) i.e., SCANSOURCE (SC3SG) and Eli Lilly go up and down completely randomly.

Pair Corralation between SCANSOURCE (SC3SG) and Eli Lilly

Assuming the 90 days trading horizon SCANSOURCE (SC3SG) is expected to generate 1.3 times less return on investment than Eli Lilly. In addition to that, SCANSOURCE (SC3SG) is 1.08 times more volatile than Eli Lilly and. It trades about 0.06 of its total potential returns per unit of risk. Eli Lilly and is currently generating about 0.08 per unit of volatility. If you would invest  34,818  in Eli Lilly and on August 26, 2024 and sell it today you would earn a total of  37,192  from holding Eli Lilly and or generate 106.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SCANSOURCE  vs.  Eli Lilly and

 Performance 
       Timeline  
SCANSOURCE (SC3SG) 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in SCANSOURCE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, SCANSOURCE (SC3SG) may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

SCANSOURCE (SC3SG) and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SCANSOURCE (SC3SG) and Eli Lilly

The main advantage of trading using opposite SCANSOURCE (SC3SG) and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANSOURCE (SC3SG) position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind SCANSOURCE and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance